Subscribe to the Good Newspaper to get good news in the mail.
Login
AboutEmailsNewspaper
Subscribe
The Good
Newspaper
What’s going right in the world
4:20 PM - Outlook positive
Good NewsEarthPeopleAnimalsHealthHuman RightsLGBTQ+Tech
Good News
Earth
EnvironmentClimate ChangeFoodHousingTech & InnovationBusinessEconomicsEducation
People
People Doing GoodHuman RightsLGBTQ+Racial JusticeMental HealthHealthRefugeesDemocracyFaithArts & Culture
Animals
All AnimalsEndangered Species
Read All Good News
EarthPeopleAnimalsHealthHuman RightsLGBTQ+Tech
Good News
EarthPeopleAnimalsHealthHuman RightsLGBTQ+Tech
Good Good Good
AboutStoreDonateNewspaperNewsletterPodcastJobs
Popular
LGBTQ+Mental HealthRacial JusticeClimate Change
Support
Subscriber LoginSubmit Good NewsFAQContact
Odds & Ends
Privacy PolicyGoodnewspaper TermsAffiliate ProgramAdvertiseRSSEditorial Guidelines
hello@goodgoodgood.co | © 2026 Good Good Good
Subscribe

  • ArticleSuggestion titleSuggestion details
Open the search page
Andrew Owen
See all contributors

Andrew Owen

Molecular and Clinical Pharmacology at University of Liverpool

Andrew Owen, PhD FSB is a Professor in the Department of Molecular and Clinical Pharmacology at the University of Liverpool, UK. He is also affiliated to the MRC Centre for Drug Safety Science and the Wolfson Centre for Personalised Medicine.

Professor Owen has contributed to over 100 original research and review publications, book chapters and patent applications. In recent years, research funding has been secured from the Medical Research Council, Engineering and Physical Sciences Research Council, US National Institutes of Health and the British Society for Antimicrobial Chemotherapy.

He is Chair of the British Society for Nanomedicine (www.BritishSocietyNanomedicine.org), a fellow of the Society of Biology and a member of the Nanomed Focus Group Steering Committee, British Pharmacological Society and Critical Path to TB Drug Regimens.

He is also a member of the editorial board for Nanomedicine: nanotechnology, biology and medicine.

Why you can trust Good Good Good:
‍

• Good Good Good is fully independent and funded by readers — with no billionaire owners or investors.
• All of our articles are researched and written by professional journalists.
• Our newsroom has a zero AI articles policy. We don’t use AI in our news stories or photos. Humans write every word.
• Good Good Good is committed to the highest newsroom standards and ethics.

→ Read Good Good Good’s Editorial Standards

All Articles from Andrew Owen

A gloved hand holds another hand without gloves

What to know about lenacapavir: US approves twice-yearly injection for HIV prevention

Long-lasting HIV drug could help people who can’t take daily PrEP pills.

Good News In Your Inbox
Join 52,000+ hopeful people who already wake up to good news every day.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We’ll never sell your email address. No spam, just good news.
Good News in your mailbox
Subscribe and get a new issue of the Good Newspaper mailed to your home every month.
Subscribe
GGG
AboutEditorial StandardsGood NewspaperGood News EmailsStoreDonate
Popular
Good NewsResourcesEarthPeopleAnimals
Support
Subscriber LoginFAQContactSubmit Good NewsAdvertiseJobs
Odds & Ends
RSSAffiliate ProgramPodcast ArchivePrivacy PolicyTerms of Service
© 2026 Good Good Good. All rights reserved. Branding and website Design by Luum Studio